12:49 Apr 21
Abbott India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Abbott India Ltd.
77/100 High Financial Strength
Quality15/100 Expensive Valuation
Valuation67/100 Technically Moderately Bullish
TechnicalSWOT
Strength
14
Weakness
4
Opportunity
0
Threat
1
66.19K
Market Cap (Cr)
49.60
PE Ratio
18.52
Price to Book Ratio
56.14
RSI
0.00 %
Net Profit Margin
Rating Based on 4 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 32748 with a high estimate of 35292 and low estimate of 31000
Current 31150.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
